Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Conference News ESC 2016

Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2

Michael O'Riordan

August 29, 2016

News Conference News ESC 2016

Radial Artery Angiograms Save Time, May Reduce Complications in Radial PCI for STEMI

Shelley Wood

August 28, 2016

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

Advertisement

Less Death, Major Bleeding With Transradial Access: Meta-analysis

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

ESC Updates Guidelines for Treating STEMI Patients

Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2

Radial Artery Angiograms Save Time, May Reduce Complications in Radial PCI for STEMI

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content